Tamura K, Lee C P, Smith P L, Borchardt R T
Department of Pharmaceutical Chemistry, University of Kansas, Lawrence 66047, USA.
Pharm Res. 1996 Nov;13(11):1663-7. doi: 10.1023/a:1016436606183.
The purpose of this study was to determine the stereospecificity of the apical oligopeptide transporter(s) for the stereoisomers of Val-Val-Val and to determine whether the interaction of these molecules with this transporter(s) could be correlated with their cellular uptake and/or transepithelial transport.
The interactions of these stereoisomers with this transporter(s) were evaluated by determining their ability to inhibit [3H]cephalexin uptake into Caco-2 cells. The metabolism of these stereoisomers was determined in a homogenate of Caco-2 cells and in the apical bathing solution over Caco-2 cell monolayers. The cellular uptake and transepithelial transport properties of these stereoisomers were studied using the Caco-2 cell monolayers.
The L-L-L tripeptide was totally degraded within 1 h in the Caco-2 cell homogenate and within 2 h when applied to the apical side of a Caco-2 cell monolayer. In contrast, 36.7 +/- 1.3% and 69.7 +/- 0.9% of L-Val-L-Val-D-Val remained after 2 h in the cell homogenate and in the apical bathing solution, respectively. The other six stereoisomers of Val-Val-Val were completely stable in the Caco-2 cell homogenate. Five of the stereoisomers (L-L-L, L-L-D, L-D-L, D-L-L, D-D-L) significantly inhibited the cellular uptake of [3H]cephalexin (91%, 62%, 14%, 45%, 16%, respectively). The other stereoisomers had no effect on the [3H]cephalexin uptake. When the cellular uptake of the stereoisomers was determined, the D-L-L and L-D-L tripeptides showed the highest intracellular concentrations (1.32 +/- 0.25 and 0.62 +/- 0.20 nmol/mg protein after a 2-h incubation, respectively). In contrast, the intracellular concentrations of the other stereoisomers were less than 0.1 nmol/mg protein. Moreover, the cellular uptake of the D-L-L and L-D-L tripeptides was inhibited by Gly-Pro by 82% and 68%, respectively, whereas Gly-Pro showed moderate to no inhibitory effect on the cellular uptake of the other stereoisomers. The permeability coefficients of the stereoisomers across the Caco-2 cell monolayers were very low (1.8 to 3.1 x 10(-7) cm/sec) and almost identical. Gly-Pro had no effect on their transepithelial transport.
These results suggest that the interaction of the Val-Val-Val stereoisomers with the apical oligopeptide transporter(s) could be a good predictor of their cellular uptake. However, since the major transepithelial transport mechanism of Val-Val-Val stereoisomers is passive diffusion via the paracellular route, the binding of these molecules to the oligopeptide transporter(s) is not a good predictor of their transepithelial transport. It appears that the stereochemical requirements for the transporter that mediates permeation of the peptide across the basolateral membrane may be different from the requirements for the apical transporter that mediates cellular uptake.
本研究旨在确定顶端寡肽转运体对缬氨酸 - 缬氨酸 - 缬氨酸立体异构体的立体特异性,并确定这些分子与该转运体的相互作用是否与其细胞摄取和/或跨上皮转运相关。
通过测定这些立体异构体抑制[³H]头孢氨苄摄取进入Caco - 2细胞的能力,评估它们与该转运体的相互作用。在Caco - 2细胞匀浆以及Caco - 2细胞单层的顶端浴液中测定这些立体异构体的代谢情况。使用Caco - 2细胞单层研究这些立体异构体的细胞摄取和跨上皮转运特性。
L - L - L三肽在Caco - 2细胞匀浆中1小时内完全降解,施加于Caco - 2细胞单层顶端侧时2小时内完全降解。相比之下,L - 缬氨酸 - L - 缬氨酸 - D - 缬氨酸在细胞匀浆中2小时后分别剩余36.7±1.3%,在顶端浴液中剩余69.7±0.9%。缬氨酸 - 缬氨酸 - 缬氨酸的其他六种立体异构体在Caco - 2细胞匀浆中完全稳定。其中五种立体异构体(L - L - L、L - L - D、L - D - L、D - L - L、D - D - L)显著抑制[³H]头孢氨苄的细胞摄取(分别为91%、62%、14%、45%、16%)。其他立体异构体对[³H]头孢氨苄摄取无影响。测定立体异构体的细胞摄取时,D - L - L和L - D - L三肽显示出最高的细胞内浓度(孵育2小时后分别为1.32±0.25和0.62±0.20 nmol/mg蛋白质)。相比之下,其他立体异构体的细胞内浓度低于0.1 nmol/mg蛋白质。此外,Gly - Pro分别抑制D - L - L和L - D - L三肽的细胞摄取82%和68%,而Gly - Pro对其他立体异构体的细胞摄取显示出中度至无抑制作用。立体异构体跨Caco - 2细胞单层的渗透系数非常低(1.8至3.1×10⁻⁷ cm/秒)且几乎相同。Gly - Pro对它们的跨上皮转运无影响。
这些结果表明,缬氨酸 - 缬氨酸 - 缬氨酸立体异构体与顶端寡肽转运体的相互作用可能是其细胞摄取的良好预测指标。然而,由于缬氨酸 - 缬氨酸 - 缬氨酸立体异构体的主要跨上皮转运机制是通过细胞旁途径的被动扩散,这些分子与寡肽转运体的结合并非其跨上皮转运的良好预测指标。似乎介导肽穿过基底外侧膜渗透的转运体的立体化学要求可能与介导细胞摄取的顶端转运体的要求不同。